Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1982 2
1988 4
1990 1
1996 3
1999 1
2000 1
2001 1
2002 4
2003 2
2004 3
2006 2
2008 5
2009 1
2011 1
2012 1
2013 8
2014 3
2015 1
2022 2
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.
Codarri Deak L, Nicolini V, Hashimoto M, Karagianni M, Schwalie PC, Lauener L, Varypataki EM, Richard M, Bommer E, Sam J, Joller S, Perro M, Cremasco F, Kunz L, Yanguez E, Hüsser T, Schlenker R, Mariani M, Tosevski V, Herter S, Bacac M, Waldhauer I, Colombetti S, Gueripel X, Wullschleger S, Tichet M, Hanahan D, Kissick HT, Leclair S, Freimoser-Grundschober A, Seeber S, Teichgräber V, Ahmed R, Klein C, Umaña P. Codarri Deak L, et al. Among authors: leclair s. Nature. 2022 Oct;610(7930):161-172. doi: 10.1038/s41586-022-05192-0. Epub 2022 Sep 28. Nature. 2022. PMID: 36171284 Free PMC article.
Clinical laboratory science.
Leclair S. Leclair S. Clin Lab Sci. 2014 Spring;27(2):66. Clin Lab Sci. 2014. PMID: 25000647 No abstract available.
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.
Eckmann J, Fauti T, Biehl M, Zabaleta A, Blanco L, Lelios I, Gottwald S, Rae R, Lechner S, Bayer C, Dekempe Q, Osl F, Carrié N, Kassem S, Lorenz S, Christopeit T, Carpy A, Bujotzek A, Bröske AM, Dekhtiarenko I, Attig J, Kunz L, Cremasco F, Adelfio R, Fertig G, Dengl S, Gassner C, Bormann F, Kirstenpfad C, Kraft T, Diggelmann S, Knobloch M, Hage C, Feddersen R, Heidkamp G, Pöschinger T, Mayoux M, Bernasconi L, Prosper F, Dumontet C, Martinet L, Leclair S, Xu W, Paiva B, Klein C, Umaña P. Eckmann J, et al. Among authors: leclair s. Blood. 2025 Jan 9;145(2):202-219. doi: 10.1182/blood.2024025987. Blood. 2025. PMID: 39476124 Free PMC article. Clinical Trial.
P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy.
Surowka M, Darowski D, Hutter-Karakoc I, Claus C, Ferrara-Koller C, Freimoser-Grundschober A, Hofer T, Sam J, Gianotti R, Sobieniecki A, Assisi D, Challier J, Leclair S, Mössner E, Amann M, Umaña P, Klein C. Surowka M, et al. Among authors: leclair s. MAbs. 2026 Dec;18(1):2602993. doi: 10.1080/19420862.2025.2602993. Epub 2025 Dec 16. MAbs. 2026. PMID: 41402230 Free PMC article.
"History is the present".
Leclair SJ. Leclair SJ. Clin Lab Sci. 2006 Winter;19(1):4. Clin Lab Sci. 2006. PMID: 16617551 No abstract available.
Our future is now!
Leclair S. Leclair S. Clin Lab Sci. 2004 Fall;17(4):194. Clin Lab Sci. 2004. PMID: 15559721 No abstract available.
In praise of reading.
Leclair SJ. Leclair SJ. Clin Lab Sci. 2002 Winter;15(1):2, 5. Clin Lab Sci. 2002. PMID: 12778945 No abstract available.
The past and the present.
Leclair S. Leclair S. Clin Lab Sci. 2003 Winter;16(1):2-3. Clin Lab Sci. 2003. PMID: 12587650 No abstract available.
49 results